郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Overexpressing cell systems are a competitive option to primary adipocytes when predicting in vivo potency of dual GPR81/GPR109A agonists.

期刊：European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences发表年份：2018作者：Joachim Almquist; Daniel Hovdal; Christine Ahlström; Ola Fjellström; Peter Gennemark; Monika Sundqvist
阅读更多 →

药效评价The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons.

期刊：Stem cell research发表年份：2018作者：Ioana Neagoe; Chang Liu; Alexander Stumpf; Yanmei Lu; Dongping He; Ross Francis; Jun Chen; Paul Reynen; Moulay Hicham Alaoui-Ismaili; Hirokazu Fukui
阅读更多 →

药效评价New insights about the peculiar role of the 28-38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection.

期刊：Biochemical pharmacology发表年份：2018作者：Mathilde Poujol de Molliens; Myriam Létourneau; Dominic Devost; Terence E Hébert; Alain Fournier; David Chatenet
阅读更多 →

药效评价Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers.

期刊：Biochimica et biophysica acta. Molecular basis of disease发表年份：2018作者：Harriet McHale-Owen; Clive Bate
阅读更多 →